Lactoferrin as an adjuvant in cancer vaccines
US8105615B2 · kind B2 · utility
0Cited by
29References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2004 |
| Grant date | Jan 31, 2012 |
| Priority date | — |
| Expiry date | Sep 17, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55516
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating cancer by administering a composition of lactoferrin (LF) in combination with cancer vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.